OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·19d ago
More News
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.
Zacks·21d ago
Best Growth Stocks to Buy for September 5th
OPRX, KT and GLDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 5, 2025.
Zacks·2mo ago
Best Growth Stocks to Buy for September 3rd
OPRX, PHIN and KT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3, 2025.
Zacks·2mo ago
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now?
Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·2mo ago
All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy
OptimizeRx (OPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks·2mo ago
Best Momentum Stock to Buy for August 21st
OPRX, BZ and ANET made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 21, 2025.
Zacks·2mo ago
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of +700.00% and +30.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?